GlaxoSmithKline announced that Iain Mackay has been appointed GSK’s next chief financial officer (CFO).
Mackay joins GSK from the global bank HSBC, where he has been group finance director for the last eight years.
Mackay holds an MA in Business Studies and Accounting from the University of Aberdeen and is a member of the Court of the University of Aberdeen.
GSK announced in May that CFO Simon Dingemans is to retire from the company in May 2019.
Mackay has also been appointed as an executive director to the GSK Board.
Mackay will join GSK on January 14, 2019.
A chartered accountant, Mackay has worked in Asia, the US and Europe and before HSBC was at General Electric, Schlumberger Dowell and Price Waterhouse.
GSK CEO Emma Walmsley said: “I’m delighted to welcome Iain to GSK.
“As a proven CFO of a complex, regulated global organisation, he brings tremendous finance experience and will be a great addition to the team.
“He is a strong leader with a track record of driving cost, cash and capital allocation discipline to deliver strategy.”
Dingemans will continue to be accountable as CFO for GSK’s financial governance through March 2019.
There will be a transition period from January 14 when Mackay will be CFO Designate, taking formal accountability as CFO from April 1.
Mackay will join the GSK corporate executive team and the board from January 14.